CFRA downgraded Intl Flavors from Buy to Sell and set a new price target of $77.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/4/2025 | $105.00 | Buy | Tigress Financial |
| 5/8/2025 | $84.00 | Equal Weight → Overweight | Barclays |
| 2/20/2025 | $77.00 | Buy → Sell | CFRA |
| 1/7/2025 | Hold → Buy | Argus | |
| 11/12/2024 | $111.00 → $110.00 | Equal-Weight → Overweight | Morgan Stanley |
| 11/8/2024 | $107.00 | Neutral → Buy | BofA Securities |
| 11/7/2024 | $109.00 | Hold → Buy | Vertical Research |
| 9/11/2024 | $116.00 → $117.00 | Outperform | Oppenheimer |
IFF (NYSE:IFF)—a global leader in flavors, fragrances, food ingredients, health and biosciences—today announced the appointment of Gina Drosos to its board of directors, effective June 16. Drosos brings more than 30 years of executive leadership experience across the retail, consumer goods, beauty and health care industries. "We are very pleased to welcome Gina to the IFF board," said Kevin O'Byrne, chair of the board. "Gina brings extensive relevant experience, deep consumer insights and a proven ability to drive innovation and lead with purpose, which aligns with our long-term strategy to deliver sustainable growth and value creation for all stakeholders." Drosos most recently served
New research reveals how food and beverage brands can lead innovation for millions facing sensory and nutritional challenges IFF (NYSE:IFF), a global leader in food, beverage, and health and wellness, has released a new report highlighting how the rapidly growing GLP-1 consumer market is reshaping the sensory experience and nutritional needs associated with eating and drinking. The report outlines how food and beverage manufacturers can better support this emerging consumer segment with products that align with their evolving preferences. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250604818126/en/ "IFF is empowering our cu
IFF (NYSE:IFF) announced today the Total Consideration (as defined below) payable in connection with its previously announced tender offers to purchase for cash: (i) up to $1,100,000,000 aggregate purchase price, excluding accrued and unpaid interest (the "Amended Pool 1 Maximum Amount"), of its 1.230% Senior Notes due 2025 (the "2025 Notes"), 1.832% Senior Notes due 2027 (the "2027 Notes"), 4.450% Senior Notes due 2028 (the "2028 Notes") and 2.300% Senior Notes due 2030 (the "2030 Notes" and collectively with the 2025 Notes, the 2027 Notes and the 2028 Notes, the "Pool 1 Notes") and (ii) up to $900,000,000 aggregate purchase price, excluding accrued and unpaid interest (the "Amended Pool 2